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INTRODUCTION
Gynecological cancers are among the leading causes of 
cancer-related deaths worldwide and the distribution and 
frequency vary from one region to the other. It accounts 
for about 10% of all cancers diagnosed in women.[1] The 
proportion of female genital cancersrange from31.6 to 35.0% 
in sub-Saharan Africa and12.7 to 13.4% in North America.[2] 
Cervical cancer is the most common pelvic malignancy 
among women worldwide.[3,4] In developed countries, 
the introduction of routine screening and treatment for 
premalignant lesions of the cervix has led to a dramatic fall in 
the incidence and mortality of cervical cancer over the past 
5 decades.[2] In developing countries like Nigeria, routine 
cervical cancer screening is rudimentary; hence there is a high 
rate of cervical cancer.[5] In developed countries, endometrial 
carcinoma is the commonest gynecological cancer; while in 
African countries, carcinoma of the cervix has been reported 
in many series to be the commonest, with most of the 
patients presenting in late stages of the disease.[2,6-8]
Ovarian cancer is the second common female genital 
cancers and a major cause of death from female genital tract 
malignancies. About 75% of the patients with ovarian cancer 
present with advanced stages of the disease due to nonspecific 
symptoms of the disease.[9] It accounted for 16.3% of the cancers 
in a study done in Ibadan, Nigeria.[5] In the United Kingdom, it 
is now the most common malignant tumor.[10]
Age and parity affect the incidence of gynecological 
cancers. Endometrial and ovarian cancers occur mainly 
later in reproductive life, while carcinoma of the cervix 
and choriocarcinoma are seen commonly in pre-or 
perimenopausal women.[11] With regards to parity, women 
of high parity have relatively low risk of developing 






A B S T R A C T
Background: Gynecological cancers are common and are among the leading causes of cancer‑related deaths worldwide. Aim: The 
objective of this study was to determine the pattern and relative frequencies of gynecological cancers as seen at the Federal Teaching 
Hospital, Abakaliki, Nigeria. Materials and Methods: A 2‑year retrospective study of female genital tract malignancies was conducted 
at the Federal Teaching Hospital, Abakaliki. The case notes of patients admitted for female genital tract malignancy between January 
1, 2012 and December 31, 2013 were retrieved from the ward admissions and discharge books and the operating theater record books. 
The data were analyzed using Statistical Package for Social Science (SPSS), IBM SPSS statistics Version 20, IBM incorporation and 
licensors  1989,2011 New York USA and the results expressed in descriptive statistics by simple percentages. Result: A total of 1,178 
women were seen during the study period, while 99 were found to have gynecological malignancy. The proportion of gynecological 
malignancies was 8.4%. Majority of the patients were in the 5th and 6th decades of life, most (60.6%) had cervical cancer, followed by 
ovarian cancer (19.2%), endometrial cancer (10.1%) vulva cancer (7.1%), and the least was choriocarcinoma (3.0%). Tumors of fallopian 
tube and vagina were not seen during the study period. Majority of the patients presented late and the common presentation was 
vaginal bleeding. Conclusion: Despite the preventable nature of cancer of cervix, it remained the most common female genital tract 
malignancy in Abakaliki, southeast Nigeria. Education and public enlightenment on the importance of routine screening and treatment 
of premalignant lesions of the cervix are necessary tools to reduce the incidence and mortality of cervical cancer.
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endometrial cancer and ovarian cancer; it is known that 
pregnancy is protective against ovarian cancer, while 
multiparity is associated with increased risk of development 
of cervical carcinoma.[12]
This paper seeks to establish a database with regards to the 
pattern and relative frequencies of gynecological cancers 
in Ebonyi State. This database will be helpful in combating 
gynecological cancer menace through actions like health 
education, screening programs, and appropriate resource 
allocation.
MATERIALS AND METHODS
The study covered a period of 2 years from 1st January 2012 
to 31st December 2013. The case records of all patients 
admitted into the gynecological ward with suspected 
gynecological cancer were retrieved from the medical 
records department. The information on clinical, surgical, 
and histopathological diagnosis was collated using a 
proforma. In addition; the type of cancer, age, and parity 
were noted. Most of the patients had histological diagnosis 
of gynecological cancers. The cases of choriocarcinoma 
were diagnosed on clinical features and confirmed by 
biochemical tests. The data were analyzed using IBM 
Statistical Package for Social Sciences (SPSS) statistics 
software version 20 (Chicago Illinois, USA), Chi-square (χ2) 
test was employed to examine the significant association 
between variables where applicable. Statistical significance 
was set at 0.05.
Ethical approval for the study was obtained from the 
ethics and research review committee of Federal Teaching 
Hospital, Abakaliki
Calculation of sample size and sampling method
The prevalence rate of 10.1% was chosen to calculate 
the minimum sample size for this study based on the 
prevalence rates of 10.1% reported in Enugu,[6] which has 
similar sociocultural and demographic characteristics and 
no such studies have been done in Ebonyi state.
The required sample size for this study was calculated using 
the following formula:
n = Z2 P (1	−	P)/d2
n = the minimum sample size required
Z = the proportion of normal distribution corresponding to 
the required significance level (5%) which is 1.96
P = the proportion of human immunodeficiency 
virus (HIV)-infected women with abnormal cervical 
cytology (10.1%)
d = the relative precision or tolerable error of the estimate 
from the study which is 5%. He estimate from this study is 
desired to be within 5% of the actual prevalence with 95% 
confidence level (5% significance level).
Thus the estimated minimum sample size was 139, but we 
examined a total of 1,178 case records.
RESULT
During the study period; 1,178 women were admitted into 
the gynecological ward and 99had gynecological cancer. 
Thus, 8.4% of the admissions were for gynecological cancers.
Age distribution [Table 1]
The mean age was 54(4) years. The largest numbers of 
gynecological cancers occurred in the 5th–6th decades of 
life; 53.6% of the cancers occurred in these age groups. The 
commonest gynecological cancers in women under 30 years 
of age were cervical cancer and choriocarcinoma; none had 
ovarian, endometrial, and vulva cancers. Cervical carcinoma 
rose sharply in occurrence from the 4thdecade oflife, and 
remained the commonest cancer in all age groups. The age 
group of women with the highest number of cervical carcinoma 
was 50–59, while that of those with ovarian cancer was 60–69 
age group. None of the women aged 60 years and above had 
choriocarcinoma [Table 1]. The age in this study was strongly 
associated with development of gynecological cancer.
Relative frequencies of gynecological 
cancers [Table 2]
The commonest gynecological cancer in the study was 
cervical carcinoma, which constituted almost 60.6% of the 
cases followed by ovarian cancer (19.2%) and endometrial 
cancer (10.1%). Vulva cancer accounted for7%, while the 
least was choriocarcinoma (3%) [Table 2]. Vaginal cancer and 
leiomyosarcoma were not seen.
Parity distribution [Table 3]
The highest parity was in women with cervical cancer and the 
lowest in those with ovarian cancer. Endometrial and vulva 
cancers were also seen among the parous women, while 
choriocarcinoma were among women of low parity [Table 3].
DISCUSSION
In this study, gynecological cancers account for 8.4% 
of gynecological admissions. This is high compared to 
4.18–4.7% reported in Port Harcourt and Zaria in Nigeria[6,13] 
and 2.8% reported in Ghana.[14] The largest numbers of 
gynecological cancers occurred in the 40–69 year group and 
is comparable to reports from Enugu and Port Harcourt.[6,15] 
Cervical cancers accounted for majority of the female genital 
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cancers in this study 60.6%. This is consistent with results 
from a similar study in Enugu, Port Harcourtin Nigeria and 
Nkyekyer from Ghana.[6,14,15]
Cervical cancer is one of the leading cancers in women 
worldwide; 80% of new cases occur in developing 
countries.[16] Cervical cancers accounted for majority 
of the female genital cancers in this study. This is 
consistent with results from a similar study in Ibadan,[5] 
Port Harcourt,[6] Nigeria, and Ghana.[14] The proportion of 
cervical cancer (60.6%) in this study is higher than 48.6% 
in Kano[17] and 57.8% reported in Ghana[14] and comparable 
to66.3% in Enugu[15] and 65% in Port Harcourt.[6] This study 
revealed an increasing incidence of carcinoma of the cervix 
in our center. This is quite understandable with early 
marriage and high number of livebirth in our region and 
absence of a national cervical cancer screening programin 
Nigeria and only sporadic screening of women who come 
for gynecological consultation in the hospital, cervical 
carcinoma is bound to be high. Routine cervical screening 
and early detection of cervical dysplasiain our center will 
lead to this low proportion of cervical cancer.
Ovarian cancer is the second most common female genital 
cancer. In this study, it accounts for 19.2% of the cases. 
This is low compared to the report from Enugu (21.1%),[15] 
12.3% from Port Harcourt,[6] 30.5% in Kano,[17] and 25.3% 
in Ghana.[14] The low incidence of ovarian cancer may be 
associated with early marriage and high family sizes of 
most families as pregnancy and breast feeding are known 
to protect against ovarian cancers.
In this study, endometrial carcinoma accounted for 
10.1% of gynecological cancers. It ismore common than 
choriocarcinoma which accounted for 3%, this is consistent 
with the findings of Nkyekyer in Ghana[14] and Kyari et al., 
in Maiduguri.[18] In Ibadan, Nigeria, choriocarcinoma was 
found to be the second most common malignant tumor 
of female genital tract.[5] Choriocarcinoma is relatively a 
disease of younger women as shown in this study. This is not 
surprising since, being a disease associated with pregnancy, 
it is more likely to occur in active reproductive life.
The incidence of vulval carcinoma in this study was 7.1%, 
which is similar to a study done in Maiduguri[18] and higher 
than 1.5% reported in Uyo[19] and 3.6% in Enugu.[15]
The data presented in this study may not be a representative 
of community prevalence rates. Another limitation of this 
study was lack of follow-up and poor documentation of vital 
information. Data were scanty on management outcome and 
records of deaths from these gynecological malignancies.
CONCLUSION
From our study we conclude that cervix carcinoma is the 
most common female genital tract malignancy in Ebonyi, 
southeast Nigeria, followed by ovarian carcinoma. The 
importance of education and public enlightenment on 
routine screening and treatment of premalignant lesions of 
female genital tract malignancies cannot be overemphasized. 
Hospital facilities for screening and regular gynecological 
examinations and well-defined follow-up surveillance 
system can change disease morbidity and mortality.
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